![Christopher Michael Bull](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christopher Michael Bull
Career history of Christopher Michael Bull
Former positions of Christopher Michael Bull
Companies | Position | Start | End |
---|---|---|---|
AFRICAN DAWN CAPITAL LIMITED | Chairman | 31/10/2014 | 12/06/2015 |
Independent Dir/Board Member | 31/10/2014 | 12/06/2015 | |
Oxyrane UK Ltd.
![]() Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Director/Board Member | - | - |
Training of Christopher Michael Bull
University of KwaZulu-Natal | Undergraduate Degree |
Statistics
International
South Africa | 3 |
United Kingdom | 2 |
Operational
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Chairman | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AFRICAN DAWN CAPITAL LIMITED | Finance |
Private companies | 1 |
---|---|
Oxyrane UK Ltd.
![]() Oxyrane UK Ltd. Pharmaceuticals: MajorHealth Technology Oxyrane UK Ltd. engages in the development of novel enzyme replacement therapies for lysosomal storage disorders. Its product is a pre-clinical ERT for Pompe Disease - a serious muscle disease - produced using engineered yeast cells. The firm develops recombinant enzyme products using a proprietary, engineered yeast expression platform based on Yarrowia lipolytica. The company was founded by Robin Kumar Mitra, Adriana L. Botes and Michael Campbell in 2006 and is headquartered in Manchester, the United Kingdom. | Health Technology |